José Manuel Esteban arrives in Paris and continues his charity challenge to Belgium

As planned, José Manuel Esteban, president of the Rotary Club Vila-real, has been able to complete his charity challenge, cycling the 1,300 kilometres that separate Paris from Vila-real in eight days and, thanks to this feat, raising funds for the Conquistando Escalones Association.
According to Esteban himself, who arrived in the city of love on Sunday night, “a promise is a promise and here I am.” Esteban says that, in reality, it has been nine days, but that one of them he was unable to complete the planned route due to the weather conditions, “the rain prevented me from going out without taking risks.”

Now, rested after having been able to sleep in a bed, he takes a break for a couple of days but, he returns to his argument of “a promise is a promise” and on Wednesday 21st August he will leave for Brakel in Belgium to participate in a Rotary meeting planned in this city.

And as Esteban indicates, “I am happy to see that the challenge of raising €2,600 has been achieved and we are close to €3,000, which I also hope will be surpassed.” So, if you have not done so yet, you can sponsor the kilometres of the journey in a very simple way; Donating from €2 by clicking the button below.

From Conquistando Escalones we have nothing but words of thanks and gratitude towards the highest representative of Rotary Vila-real. As the president of the Association, Abrahán Guirao, pointed out, it is not always easy to obtain funds for research into Limb-girdle Muscular Dystrophy 1F/D2 (LMGDD2) so “finding people like José Manuel, who in a completely altruistic way, launch actions that help us raise funds to research our disease is a stroke of luck and we couldn’t be more grateful.”

It is worth remembering that Esteban met Abrahán Guirao last summer thanks to the filming of the series Abrahán con ene. From that moment on, it was clear to him that he wanted to promote some initiative in favor of the Association and, therefore, of medical research on LGMDD2 to find a definitive treatment or cure for this disease considered rare and which, in turn, will serve as a step towards a more effective treatment against the AIDS virus since the mutation caused by LGMDD2 makes those who suffer from it immune to HIV, so the findings on one disease benefit the other.